IWR-1

CAT:
804-HY-12238-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
IWR-1 - image 1

IWR-1

  • Description:

    IWR-1 (IWR-1-endo) is a tankyrase inhibitor targeting Wnt/β-catenin (IC50 = 180 nM) . IWR-1 compromises critical steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets. IWR-1 promotes β-catenin phosphorylation by promoting stability of Axin-scaffolded destruction complexes. IWR-1 can be studied in research for anti-tumor purposes, and diseases such as osteosarcoma, colorectal cancer and psoriasis[1][2][4].
  • Product Name Alternative:

    Endo-IWR 1; IWR-1-endo
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Organoid; Wnt
  • Type:

    Reference compound
  • Related Pathways:

    Stem Cell/Wnt
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/IWR-1.html
  • Purity:

    99.60
  • Solubility:

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles:

    O=C (NC1=C2N=CC=CC2=CC=C1) C3=CC=C (N (C ([C@]4 ([H]) [C@] (C5) ([H]) C=C[C@]5 ([H]) [C@]64[H]) =O) C6=O) C=C3
  • Molecular Formula:

    C25H19N3O3
  • Molecular Weight:

    409.44
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]Sara R. Martins-Neves, et al., IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft, Cancer Letters, Volume 414, 2018, Pages 1-15, ISSN 0304-3835. |[2]Lee SC, et al., IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression. Oncotarget. 2015 Sep 29;6 (29) :27146-59.|[3]Wang, W. M., et al., IWR-1 attenuates the promotional effect of IL-36γ in a mouse model of psoriasis. BMC immunology, 25 (1), 78.|[4]Chen, B., Dodge, M.E., Tang, W., et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5 (2), 100-107 (2009) .
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • CAS Number:

    1127442-82-3